Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.
about
Advances in use of the 5-HT3 receptor antagonists.Control of nausea and vomiting after chemotherapy: what is the evidence?5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial.Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatinGranisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyAnti-emetic therapy in cancer chemotherapy: current status.Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.Development of antiemetic therapy in cancer patients.Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
P2860
Q33181781-3439F978-F963-4035-B92E-2193596C8F7DQ34773714-AAFBFE06-CAF4-40AA-9186-BC4E4E00C6DBQ35146420-C6B9B5BB-8DE5-4B48-9DF6-3A1858CCBBEDQ35779340-3581C9AE-384D-489D-AC62-9FD3DC966D88Q36134463-8C22BBEF-E57F-4F9A-A1D4-655DDCCCC2A8Q36617964-9116D8C2-0678-44AD-AA07-CF651DC42BF8Q36909501-401B06AF-A266-4B33-A383-B375D9FB3609Q38241998-49B559A7-1C12-46A4-AC36-88FB29F85187Q40405376-23CBC498-E9E9-4EFB-A0B8-46C3B2494FE8Q48687384-9F849AF5-BFE2-4FE5-8455-9EF827369D3D
P2860
Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Ondansetron plus metopimazine ...... ately emetogenic chemotherapy.
@en
Ondansetron plus metopimazine ...... ately emetogenic chemotherapy.
@nl
type
label
Ondansetron plus metopimazine ...... ately emetogenic chemotherapy.
@en
Ondansetron plus metopimazine ...... ately emetogenic chemotherapy.
@nl
prefLabel
Ondansetron plus metopimazine ...... ately emetogenic chemotherapy.
@en
Ondansetron plus metopimazine ...... ately emetogenic chemotherapy.
@nl
P2093
P1476
Ondansetron plus metopimazine ...... ately emetogenic chemotherapy.
@en
P2093
Boesgaard M
Dombernowsky P
Herrstedt J
Sigsgaard T
P304
P356
10.1056/NEJM199304153281502
P407
P577
1993-04-01T00:00:00Z